Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2021 | 07-2021 | 04-2021 | 01-2021 | 10-2020 | |
| Sales | -1 | 0 | 0 | 513 | 0 |
| Gross Profit | -1 | N/A | N/A | 513 | N/A |
| Operating Expenses | 4,077 | 4,388 | 2,437 | 2,746 | 2,242 |
| Operating Income | -4,078 | -4,388 | -2,437 | -2,233 | -2,242 |
| Other Income | 7 | 0 | 0 | 1 | 1 |
| Pre-tax Income | -4,071 | -4,388 | -2,437 | -2,232 | -2,241 |
| Net Income Continuous | -4,071 | -4,388 | -2,437 | -2,232 | -2,241 |
| Minority Interests | -58 | -54 | -38 | -24 | -17 |
| Net Income | $-4,013 | $-4,334 | $-2,399 | $-2,208 | $-2,224 |
| EPS Basic Total Ops | -0.14 | -0.14 | -0.08 | -0.09 | -0.09 |
| EPS Basic Continuous Ops | -0.14 | -0.14 | -0.09 | -0.09 | -0.09 |
| EPS Diluted Total Ops | -0.14 | -0.14 | -0.08 | -0.09 | -0.09 |
| EPS Diluted Continuous Ops | -0.14 | -0.14 | -0.09 | -0.09 | -0.09 |
| EBITDA(a) | $-4,062 | $-4,373 | $-2,422 | $-2,219 | $-2,229 |